The Search for Optimal Antithrombotic Therapy With LAAO: Are We There Yet?

JACC Cardiovasc Interv. 2023 Nov 27;16(22):2719-2721. doi: 10.1016/j.jcin.2023.09.019. Epub 2023 Nov 8.

Authors

Matthew W Sherwood¹, Amit N Vora²

Affiliations

¹ Inova Heart and Vascular Institute, Falls Church, Virginia, USA. Electronic address: matthew.sherwood@inova.org.
² Yale University School of Medicine, New Haven, Connecticut, USA.

PMID: 37943197
DOI: 10.1016/j.jcin.2023.09.019

No abstract available

Keywords: atrial fibrillation; bleeding; stroke.

Publication types

Editorial

MeSH terms

Anticoagulants
Atrial Appendage*
Atrial Fibrillation* / therapy
Fibrinolytic Agents / adverse effects
Humans
Stroke*
Treatment Outcome

Substances

Fibrinolytic Agents
Anticoagulants